Laprost
Brand Name: Laprost
Generic Name: Latanoprost
Active
Registration Number
DR-XY40933
Dosage Form
Opthalmic Solution
Issuance Date
May 26, 2022
Expiry Date
June 1, 2027
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength0.05 mg/mL
PackagingLDPE Opaque bottle/HDPE
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Anti-Glaucoma
A
Application
Renewal
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
LatanoprostActive
Monograph: Latanoprost